AzTrials
AzTrials

Child LanguageTWMBNCT07132411

Talk With Me Baby: Leveraging Well-Child Care to Enhance the Early Home Language Environment

A study testing Patients in Talk With Me Baby Clinics and Patients in Care-As-Usual Clinics in people with Child Language and Language Delay, run by University of Kansas Medical Center at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Language-rich interactions with a parent or caregiver can serve as a protective factor for young children, by supporting their language development and other positive long-term outcomes, but existing interventions have not had the necessary reach to families who need this information the most. Read more about this study

Who is it for?
Ages 1 day to 2 years
What is being tested?
Patients in Talk With Me Baby Clinics and Patients in Care-As-Usual Clinics
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
2 sitesUnited States
Study dates
5 Feb 2026to Jun 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child must be enrolled prior to attending their 2-month WCC visit, age 1 month (+/- 30 days)
  • Full term (>=37 weeks gestation)
  • Singleton birth
  • Home language of English and/or Spanish
  • Child must receive WCC at a participating clinic
  • A primary care practice (family medicine or pediatric model) that delivers WCC for children from 0-36 months old
  • A minimum of 30% Medicaid/uninsured visits/year
  • A minimum of 300 unique 0 to 36-month-old patients/year

Who cannot join

  • Child with a severe congenital disorder that would affect neurodevelopmental outcomes, or hearing impairment that could affect participation
  • Parent does not live with or spend >=2 days/week with the child
  • Family does not plan to continue services at the clinic

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Brenda J Salley, PhD contact

913-945-7944

bsalley@kumc.edu

United States2 sites, 2 recruiting
  • Emory University

    Atlanta, Georgia, 30322

    Susan N Brasher, PhD, RN, CPNP, FAAN, 404-727-6490, susan.n.brasher@emory.edu

    Susan N Brasher, PhD, RN, CPNP, FAAN

    Not yet recruiting
  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

    Brenda J Salley, PhD, 913-945-7944, bsalley@kumc.edu

    Megan Olalde, MS, RD, CCRP, 913-588-2042, molalde@kumc.edu

    Recruiting

Other trials in United States

About this study

Language-rich interactions with a parent or caregiver can serve as a protective factor for young children, by supporting their language development and other positive long-term outcomes, but existing interventions have not had the necessary reach to families who need this information the most. This study utilizes the primary care setting as a low cost, scalable way to deliver language promotion intervention. Specifically, we will test the effectiveness and explore implementation of language promotion intervention (Talk With Me Baby) that embeds within anticipatory guidance during pediatric well-child care to boost early language development and optimize health, academic, and economic outcomes.

Read the detailed description

The quality of early language interactions with parents and caregivers in early childhood has long-term implications for a child's social, economic, and physical heath. Differences in the home language environment (HLE) are well established and cross all sociodemographic characteristics. Although several decades of research have identified evidence-based strategies that enhance the HLE and improve child outcomes, they have failed to reduce population-level differences in child language development and long-term outcomes. The study utilizes Talk With Me Baby (TWMB) as a novel tool to increase language building interactions between parent/caregiver and child. Because TWMB is delivered in the primary care setting (which reaches up to 98% of families with infants and toddlers), it is scalable, low-cost, and universal. With TWMB, healthcare providers can embed evidence-based language promotion into their well-child care (WCC) anticipatory guidance for all children age 0-3 years. TWMB builds on decades of well-controlled language intervention efficacy trials and has been deployed clinically for 8+ years. This study is a type 1 hybrid effectiveness implementation trial to measure the impact of TWMB on gains in the HLE and subsequent child language outcomes. The trial is both randomized and controlled across 2 sites: a TWMB intervention group (8 clinics) and a care-as-usual control group (8 clinics). In TWMB clinics, providers and care teams will be trained to deliver TWMB during all 2-24 month WCC visits. Across TWMB and control clinics, we will enroll 25 parent-child dyads in each clinic (n=400 total) prior to their 2-month WCC visit and follow them through their 24-month WCC visit.

Being tested
Patients in Talk With Me Baby Clinics, Patients in Care-As-Usual Clinics
Keywords
well-child care, primary care practices, home language environment, preventative intervention, language development, language promotion intervention
Medical subject headings
Language Development Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients in Talk With Me Baby ClinicsBehavioural

    Parent-child participants in TWMB clinics will attend their regular WCC visits (scheduled per routine clinic processes) following the AAP Periodicity Schedule.

  • Patients in Care-As-Usual ClinicsBehavioural

    Parent-child participants in Care-As-Usual clinics will attend their regular WCC visits (scheduled per routine clinic processes) following the AAP Periodicity Schedule. Measures will be completed at five time points.

Study groups in NCT07132411
Study groupRoleWhat they receive
Talk With Me Baby ClinicsExperimentalIn TWMB clinics, TWMB will be delivered within usual WCC workflows for anticipatory guidance during the clinical encounter. TWMB is delivered by the primary clinician (i.e., pediatrician/family medicine physician; physician assistant; nurse practitioner) and/or a clinician and care team. TWMB targets key evidence-based language promotion strategies that previous research has shown to improve child language outcomes. TWMB training involves didactic and practice-based instruction (CME/CNE) that includes: (a) a brief review of the science behind why language promotion matters; (b) focused instruction (with video examples and modeling) on how to deliver components of TWMB, including the TWMB Checklist and Language Nutrition Prescription; and (c) live practice and role play with the trainer on delivering TWMB across child ages and families.
Receives: Behavioral: Patients in Talk With Me Baby Clinics
Care-As-Usual ClinicsActive comparatorProviders/care teams will deliver care-as-usual WCC visits for all children. Parent-child participants in Control clinics will receive WCC anticipatory guidance care as usual. No treatment control is in line with the literature on randomized behavioral/educational interventions.
Receives: Behavioral: Patients in Care-As-Usual Clinics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in parent language-promotion behavior

    Change in parent language-promotion behavior (as measured by Language Environment Analysis [LENA] Conversational Turn Count) at each assessment time point (child age 1, 6, 12, and 18 months old) for parent-child dyads in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 1, 6, 12, and 18 months old

  2. Child total language

    Child language (as measured by the Preschool Language Scale-5 [PLS-5/PLS-5 Spanish] for Total Language) at child age 24 months old for parent-child dyads in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 24 months old

  3. Child receptive language

    Child receptive language (as measured by the Preschool Language Scale-5 [PLS-5/PLS-5 Spanish] for Receptive Language) at child age 24 months old for parent-child dyads in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 24 months old

  4. Child expressive language

    Child expressive language (as measured by the Preschool Language Scale-5 [PLS-5/PLS-5 Spanish] for Expressive Language) at child age 24 months old for parent-child dyads in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 24 months old

Secondary outcomes (9)
  1. Change in parent language promotion knowledge

    Parent language promotion knowledge (as measured using the Survey of Parent Expectations \& Knowledge [SPEAK] total score) at each child age 1, 12, and 24 months old for parent-child dyads in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 1, 12, and 24 months old

  2. Change in Child vocalizations and verbalizations

    Change in child vocalizations and verbalizations (as measured by Language Environment Analysis [LENA] Child Vocalization Count percentile scores) at child age 1, 6, 12, and 18 months old for children in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 1, 6, 12, and 18 months old

  3. Change in child receptive vocabulary

    Change in child receptive vocabulary (as measured by MacArthur-Bates Communicative Development Inventories [MBCDI] Short Form and Spanish Inventario Short Form I/II) at child age 12, 18, and 24 months for children in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 12, 18, and 24 months old

  4. Change in child expressive vocabulary

    Change in child expressive vocabulary (as measured by MacArthur-Bates Communicative Development Inventories [MBCDI] Short Form and Spanish Inventario Short Form I/II) at child age 12, 18, and 24 months for children in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 12, 18, and 24 months old

  5. Parent contingent responding scores for a subset of the sample

    Parent contingent responding scores (as measured by behavioral coding of home video recordings during daily routines) at child age 18 months for children in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 18 months old

  6. Parent contingent verbal scaffolding scores for a subset of the sample

    Parent verbal scaffolding scores (as measured by behavioral coding of home video recordings during daily routines) at child age 18 months for children in TWMB clinics, compared to care-as-usual clinics.

    Measured: Child age 18 months old

  7. Feasibility of intervention for treatment arm only

    Feasibility of intervention (as assessed by the Feasibility of Intervention Measure [FIM]at post-intervention. The study team also plans to conduct interviews with the clinics with the highest and lowest FIM scores to identify facilitators and barriers to implementation.

    Measured: Upon study completion, approximately 2 years

  8. Acceptability of intervention for treatment arm only

    Acceptability of intervention (as assessed by the Acceptability of Intervention Measure [AIM]) at post-intervention. The study team also plans to conduct interviews with the clinics with the highest and lowest AIM scores to identify facilitators and barriers to implementation.

    Measured: Upon study completion, approximately 2 years

  9. Appropriateness of intervention for treatment arm only

    Appropriateness of intervention (as assessed by the Intervention Appropriateness Measure [IAM]) at post-intervention. The study team also plans to conduct interviews with the clinics with the highest and lowest IAM scores to identify facilitators and barriers to implementation.

    Measured: Upon study completion, approximately 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2025
  2. Study start5 Feb 2026
  3. Primary completionMar 2029 (estimated)
  4. Study completionJun 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A pragmatic type 1 hybrid effectiveness-implementation cluster randomized controlled trial
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07132411
Sponsor's protocol ID
STUDY00151172
Other IDs
5R01HD112446-02
Acronym
TWMB
Status last verified
Mar 2026
First submitted
2 Jul 2025
Last updated
24 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Patients in Talk With Me Baby Clinics and Patients in Care-As-Usual Clinics in people with Child Language and Language Delay, run by University of Kansas Medical Center at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Brenda J Salley, PhD (913-945-7944, bsalley@kumc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in parent language-promotion behavior (time frame: Child age 1, 6, 12, and 18 months old). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in